tiprankstipranks
Trending News
More News >
INNO-GENE Spolka Akcyjna (DE:WQ3)
FRANKFURT:WQ3
Germany Market

INNO-GENE Spolka Akcyjna (WQ3) Financial Statements

Compare
0 Followers

INNO-GENE Spolka Akcyjna Financial Overview

INNO-GENE Spolka Akcyjna's market cap is currently €18.24M. The company's EPS TTM is €-0.016; its P/E ratio is 145.77; INNO-GENE Spolka Akcyjna is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 22.39M$ 3.21M$ 1.23M$ 2.43M$ 2.44M
Operating Income$ 9.60M$ 487.14K$ -311.09K$ 431.44K$ 690.57K
EBITDA$ 9.57M$ 4.28M$ 610.08K$ 1.23M$ 2.06M
Net Income$ 6.14M$ 366.31K$ -164.85K$ 422.55K$ 804.10K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 15.21M$ 20.26M$ 17.17M$ 18.33M$ 19.49M
Total Debt$ 1.19M$ 2.95M$ 1.25M$ 1.07M$ 1.04M
Net Debt$ -2.73M$ 2.67M$ 1.23M$ 1.04M$ 257.82K
Total Liabilities$ 7.05M$ 16.39M$ 14.69M$ 15.68M$ 17.24M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -1.13M$ 29.12K$ 36.07K$ -765.05K$ -561.18K
Operating Cash Flow$ -1.13M$ 29.12K$ 996.95K$ 2.31M$ -561.18K
Investing Cash Flow
Financing Cash Flow
Currency in USD

INNO-GENE Spolka Akcyjna Earnings and Revenue History

INNO-GENE Spolka Akcyjna Debt to Assets

INNO-GENE Spolka Akcyjna Cash Flow

INNO-GENE Spolka Akcyjna Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.